Amrize (NYSE:AMRZ) Insider Nollaig Forrest Buys 2,000 Shares of Stock

Amrize Ltd (NYSE:AMRZGet Free Report) insider Nollaig Forrest acquired 2,000 shares of the stock in a transaction that occurred on Friday, May 22nd. The shares were bought at an average price of $50.25 per share, for a total transaction of $100,500.00. Following the purchase, the insider directly owned 20,139 shares of the company’s stock, valued at approximately $1,011,984.75. This trade represents a 11.03% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Amrize Trading Up 2.8%

Shares of NYSE:AMRZ opened at $51.37 on Wednesday. The stock has a market capitalization of $28.41 billion and a price-to-earnings ratio of 24.58. Amrize Ltd has a 1-year low of $44.12 and a 1-year high of $65.94. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. The company has a 50 day moving average price of $54.58 and a 200 day moving average price of $55.11.

Amrize (NYSE:AMRZGet Free Report) last issued its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The business had revenue of $2.18 billion for the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.The firm’s revenue was up 4.7% compared to the same quarter last year. On average, research analysts anticipate that Amrize Ltd will post 2.76 EPS for the current fiscal year.

Amrize Cuts Dividend

The firm also recently announced a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is presently 21.05%.

Hedge Funds Weigh In On Amrize

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Glenmede Trust Co. NA acquired a new position in Amrize in the 1st quarter worth approximately $270,000. Janus Henderson Group PLC boosted its stake in Amrize by 9.5% in the 1st quarter. Janus Henderson Group PLC now owns 36,878 shares of the company’s stock worth $2,066,000 after purchasing an additional 3,200 shares during the period. Amundi boosted its stake in Amrize by 30.9% in the 1st quarter. Amundi now owns 1,654,739 shares of the company’s stock worth $92,698,000 after purchasing an additional 390,750 shares during the period. Adalta Capital Management LLC boosted its stake in Amrize by 15.4% in the 1st quarter. Adalta Capital Management LLC now owns 12,580 shares of the company’s stock worth $703,000 after purchasing an additional 1,680 shares during the period. Finally, Royal Bank of Canada boosted its stake in Amrize by 18.4% in the 1st quarter. Royal Bank of Canada now owns 442,726 shares of the company’s stock worth $24,801,000 after purchasing an additional 68,787 shares during the period.

Analysts Set New Price Targets

AMRZ has been the subject of a number of research reports. JPMorgan Chase & Co. raised their target price on shares of Amrize from $60.00 to $70.00 and gave the stock an “overweight” rating in a report on Thursday, March 5th. Berenberg Bank set a $70.00 target price on shares of Amrize in a report on Thursday, February 19th. Citigroup reduced their target price on shares of Amrize from $76.00 to $66.00 and set a “buy” rating for the company in a report on Monday, May 4th. Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 target price for the company in a report on Friday, May 1st. Finally, Wells Fargo & Company decreased their price objective on shares of Amrize from $66.00 to $65.00 and set an “overweight” rating for the company in a research note on Wednesday, April 15th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $64.86.

Check Out Our Latest Research Report on Amrize

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Stories

Insider Buying and Selling by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.